SIAH1/SIAH2 Antibody

What are SIAH1 and SIAH2 proteins and why are they important targets for antibody detection?

SIAH1 and SIAH2 are E3 ubiquitin ligases involved in ubiquitination and proteasome-mediated degradation of specific proteins. SIAH1 has been implicated in the development of certain forms of Parkinson's disease, regulation of cellular response to hypoxia, and induction of apoptosis . SIAH2 plays roles in regulating cellular response to hypoxia, DNA damage repair processes, and replication fork recovery . Both proteins are members of the seven in absentia homolog (SIAH) family and share functional similarities, including the ability to compensate for each other when one is suppressed . Their critical roles in protein degradation pathways make them important targets for research in cardiovascular disease, cancer biology, and neurodegenerative disorders.

What molecular weights should be observed for SIAH1/SIAH2 proteins in Western blot experiments?

When performing Western blot analysis for SIAH proteins, researchers should expect to observe SIAH2 at approximately 35-40 kDa based on its calculated molecular weight of 324 amino acids (35 kDa) . The discrepancy between calculated and observed molecular weights may be attributed to post-translational modifications. When conducting experiments, it's advisable to include positive controls such as mouse brain tissue lysates, which have been confirmed to express detectable levels of SIAH2 . Protein abundance of SIAH can be quantified using image analysis software such as ImageJ, as demonstrated in published research protocols .

What species reactivity can be expected with commercially available SIAH1/SIAH2 antibodies?

Available SIAH2 antibodies typically show reactivity with human, mouse, and rat samples . When selecting an antibody for your research, it's important to verify the cross-reactivity with your species of interest. For example, antibody catalog #12651-1-AP has been validated for reactivity with human, mouse, and rat samples across multiple applications including Western blot, immunohistochemistry, immunofluorescence, and immunoprecipitation . The specificity should be verified using appropriate positive controls for each species of interest before proceeding with experimental applications.

What are the optimal applications and dilutions for SIAH1/SIAH2 antibodies?

Based on published research and commercial antibody documentation, SIAH1/SIAH2 antibodies can be used in multiple applications with the following recommended dilutions:

Optimization is crucial as the ideal dilution may be sample-dependent . For IHC applications, antigen retrieval with TE buffer at pH 9.0 is suggested, although citrate buffer at pH 6.0 can serve as an alternative . For all applications, it is recommended to perform titration experiments to determine the optimal antibody concentration for your specific experimental system.

How should researchers design experiments to study both SIAH1 and SIAH2 given their compensatory mechanisms?

When designing experiments to study SIAH1 and SIAH2, researchers must account for their compensatory relationship. Research has demonstrated that RNAi silencing of SIAH1 leads to up-regulated SIAH2 expression by 1.37 ± 0.11-fold, and similarly, SIAH2 RNAi results in increased SIAH1 by 1.34 ± 0.10-fold . This compensation phenomenon has been confirmed in both endothelial cells and mouse myoblast cell line C2C12 .

For effective experimental design:

• When targeting either protein individually, always assess the expression level of the other isoform

• For complete inhibition of SIAH function, use simultaneous knockdown of both SIAH1 and SIAH2

• In co-transfection experiments with both SIAH1 and SIAH2 siRNAs, researchers have observed a 1.57 ± 0.06-fold increase in downstream target proteins like DCC

• Include appropriate controls to account for off-target effects in RNAi experiments

• Consider using CRISPR/Cas9-mediated knockout models for more complete elimination of both proteins

This dual-targeting approach is especially important for studies examining downstream effects, as incomplete inhibition may lead to misleading results due to functional compensation.

What are the optimal protocols for detecting SIAH1/SIAH2 interaction with target proteins?

For detecting interactions between SIAH1/SIAH2 and their target proteins, immunoprecipitation (IP) followed by Western blot analysis is the recommended approach. Based on published protocols:

• Cell extracts should be precleared with Protein G-Sepharose beads to minimize non-specific binding

• Incubate the precleared lysate with appropriate SIAH1/SIAH2 antibodies (0.5-4.0 μg for 1.0-3.0 mg of total protein) at 4°C for 4 hours

• Add fresh Protein G-Sepharose beads and continue incubation overnight at 4°C with rotation

• Wash the beads at least three times in RIPA buffer

• Resuspend beads in SDS sample buffer and boil for 5 minutes

• Analyze immune complexes by Western blotting

For studying dynamic interactions, cycloheximide chase analysis can be performed. Transfect cells with SIAH2 siRNA or Flag-SIAH2 vector, wait 48 hours, then treat with cycloheximide (10 μg/ml) for various time points . This approach allows assessment of protein stability and degradation rates. Quantification of protein levels can be performed using ImageJ software for consistent analysis across experiments.

How can researchers accurately assess SIAH1/SIAH2 function in ubiquitination experiments?

To assess SIAH1/SIAH2 function in ubiquitination experiments, researchers should implement the following methodological approach:

• In vitro ubiquitination assay:

  • Express and purify recombinant SIAH1/SIAH2 proteins along with potential substrate proteins

  • Set up reactions containing E1 activating enzyme, E2 conjugating enzyme, ubiquitin, ATP, and the purified E3 ligase (SIAH1/SIAH2)

  • Incubate at 30°C for 1-2 hours

  • Analyze ubiquitination by SDS-PAGE followed by Western blotting with anti-ubiquitin antibodies

• In vivo ubiquitination assay:

  • Transfect cells with plasmids expressing His-tagged ubiquitin, SIAH1/SIAH2, and the substrate of interest

  • After 24-48 hours, treat cells with proteasome inhibitor (e.g., MG132) for 4-6 hours before harvesting

  • Perform His-pull down under denaturing conditions to isolate ubiquitinated proteins

  • Detect ubiquitination of specific substrates by Western blotting with antibodies against the substrate

• Controls:

  • Include RING domain mutants of SIAH1/SIAH2 that lack E3 ligase activity

  • Perform parallel experiments with both SIAH1 and SIAH2 due to their compensatory mechanisms

  • Include negative controls without the E3 ligase component

When analyzing ubiquitination mediated by SIAH1/SIAH2, remember that these proteins have been shown to compensate for each other's function, making dual inhibition necessary for comprehensive functional analysis .

What are common issues in detecting SIAH1/SIAH2 proteins and how can they be resolved?

Researchers often encounter challenges when detecting SIAH1/SIAH2 proteins. Here are common issues and their solutions:

• Low signal intensity:

  • Increase antibody concentration within recommended range (1:200-1:1000 for WB)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use enhanced chemiluminescence (ECL) substrates with higher sensitivity

  • Increase protein loading (up to 50-60 μg per lane)

• Multiple bands or non-specific binding:

  • Increase blocking time or concentration (5% BSA or milk)

  • Add 0.1-0.3% Triton X-100 to wash buffers

  • Increase wash times and number of washes

  • Use more specific antibodies or validation with knockdown controls

• Variable expression between experiments:

  • Standardize cell culture conditions and harvesting protocols

  • Use internal loading controls consistently (actin is commonly used)

  • Harvest cells at consistent confluence and time points

  • Consider the compensatory upregulation between SIAH1 and SIAH2

• Poor immunoprecipitation efficiency:

  • Optimize antibody amount (0.5-4.0 μg for 1.0-3.0 mg total protein)

  • Extend incubation time with antibody (4-16 hours)

  • Ensure proper preclearing of lysates with Protein G-Sepharose

  • Consider crosslinking antibodies to beads for cleaner results

For all troubleshooting approaches, it's advisable to include positive control samples such as mouse brain tissue for Western blot and MCF-7 cells for immunoprecipitation and immunofluorescence applications .

How can researchers distinguish between specific and non-specific signals when using SIAH1/SIAH2 antibodies?

Distinguishing between specific and non-specific signals is crucial for accurate data interpretation when using SIAH1/SIAH2 antibodies. Implement these validation strategies:

• Use of knockdown/knockout controls:

  • Employ siRNA targeting SIAH1/SIAH2 as negative controls

  • Remember that due to compensation, single knockdowns may show partial reduction (SIAH1 and SIAH2 siRNAs reduced protein levels to 39.3 ± 9.6% and 58.6 ± 3.0% of control, respectively)

  • For complete validation, use double knockdown of both SIAH1 and SIAH2

• Molecular weight verification:

  • Confirm that detected bands align with the expected molecular weight (35-40 kDa for SIAH2)

  • Be aware that post-translational modifications may cause slight shifts in observed molecular weight

• Antibody specificity tests:

  • Perform peptide competition assays by pre-incubating antibody with immunizing peptide

  • Use multiple antibodies targeting different epitopes of the same protein

  • Compare results across different detection methods (WB, IP, IHC)

• Positive controls:

  • Include known positive samples (e.g., mouse brain tissue for SIAH2)

  • Use recombinant SIAH1/SIAH2 proteins as positive controls in Western blot

• Negative controls:

  • Include secondary antibody-only controls to detect non-specific binding

  • Use tissues or cell lines with known low expression of SIAH1/SIAH2

By implementing these validation strategies, researchers can confidently distinguish between specific and non-specific signals when using SIAH1/SIAH2 antibodies.

How can SIAH1/SIAH2 antibodies be optimized for studying their role in cardiovascular protection?

To optimize SIAH1/SIAH2 antibody use in cardiovascular research, particularly for studying their role in cardioprotection:

• In vivo antibody validation:

  • Verify antibody specificity in cardiac tissue through immunofluorescence assays

  • Research has confirmed successful knockdown of corresponding SIAH isoforms in mouse heart using this approach

• Experimental models:

  • For ex vivo studies, utilize the Langendorff system for ischemia/reperfusion (I/R) injury models

  • For in vivo models, perform coronary occlusion (30 min) followed by reperfusion (24h)

  • Measure infarct size as a percentage of area at risk (Inf/AAR) and left ventricle size (Inf/LV)

• Functional assessment:

  • Combine SIAH1/SIAH2 detection with echocardiography measurements

  • Key parameters include fractional shortening and ejection fraction, which were significantly increased in SIAH1/2 siRNA-treated hearts after I/R compared to controls

• Downstream target analysis:

  • Monitor DCC protein levels, which increased by 2.92 ± 0.39-fold in I/R-injured hearts with SIAH1/2 knockdown

  • Combine with netrin-1 treatment for additive cardioprotective effects

• Tissue-specific analysis:

  • Use specific tissue preparation protocols for heart samples to preserve protein integrity

  • Consider combined analysis of cardiac endothelial cells and cardiomyocytes to understand cell-specific effects

When studying SIAH1/2 in cardiovascular protection, note that SIAH1/2 knockdown significantly reduced infarct size (from 55.6 ± 1.4% to 40.6 ± 4.5% ex vivo) and improved cardiac function post-I/R injury .

What are the best approaches for studying SIAH2's role in DNA damage repair using antibody-based techniques?

To effectively study SIAH2's role in DNA damage repair using antibody-based techniques:

• Experimental design for double-strand break (DSB) repair:

  • Use SIAH2 antibodies in combination with antibodies against DNA repair proteins, particularly CtIP

  • SIAH2 has been identified as a novel regulator of CtIP that controls its activity in homologous recombination (HR)-mediated DSB repair

  • Design experiments to detect protein-protein interactions between SIAH2 and repair factors using co-immunoprecipitation

• Replication stress response analysis:

  • Study SIAH2's role in replication fork recovery using immunofluorescence to co-localize SIAH2 with replication fork markers

  • Design pulse-chase experiments to track replication dynamics with antibody detection of SIAH2

• Protein stability assessment:

  • Utilize cycloheximide chase analysis with SIAH2 antibody detection

  • Transfect cells with SIAH2 siRNA or Flag-SIAH2 vector 48 hours before treatment with cycloheximide (10 μg/ml)

  • Monitor protein degradation over time using Western blot and quantify using ImageJ software

• Chromatin association studies:

  • Perform chromatin fractionation followed by Western blot analysis with SIAH2 antibodies

  • Compare SIAH2 chromatin association before and after DNA damage induction

• Microscopy approaches:

  • Use immunofluorescence to track SIAH2 localization to sites of DNA damage

  • Combine with γH2AX staining to correlate with DSB sites

  • Analyze using confocal microscopy for high-resolution co-localization studies

When designing these experiments, remember that unlike SIAH1 (which inhibits DSB repair), SIAH2 plays a critical role in promoting DNA end resection and recovery of stalled replication forks, thereby maintaining chromosomal stability .

What are the optimal protocols for detecting SIAH1/SIAH2 in different tissue types?

Different tissue types require optimized protocols for effective SIAH1/SIAH2 detection:

• Brain tissue:

  • Mouse brain tissue serves as an excellent positive control for SIAH2 detection

  • For IHC, use antigen retrieval with TE buffer at pH 9.0 (alternatively, citrate buffer at pH 6.0)

  • Recommended dilution for IHC: 1:50-1:500

  • For Western blot, homogenize tissue in RIPA buffer with protease inhibitors

• Cardiac tissue:

  • Validated in mouse heart models for SIAH1/2 detection

  • For immunofluorescence in cardiac tissue, fixation in 4% paraformaldehyde followed by cryosectioning yields optimal results

  • Successful SIAH1/2 knockdown in mouse heart has been confirmed through immunofluorescence assays

• Cell culture samples:

  • MCF-7 cells serve as reliable positive controls for immunoprecipitation and immunofluorescence of SIAH2

  • C2C12 mouse myoblast cells have been used to study SIAH1/SIAH2 compensation mechanisms

  • When harvesting adherent cells, avoid overexposure to trypsin which may affect protein integrity

• Tissue preparation considerations:

  • Fresh frozen tissue is preferred for protein analysis

  • For FFPE tissues, extended antigen retrieval may be necessary

  • Consider specialized extraction buffers with denaturation agents for difficult tissues

When working with tissues that express both SIAH1 and SIAH2, remember that detecting compensation effects requires simultaneous analysis of both proteins, as knockdown of one isoform leads to upregulation of the other .

How should researchers approach SIAH1/SIAH2 detection in models of hypoxia and stress response?

For effective SIAH1/SIAH2 detection in hypoxia and stress response models:

• Hypoxia model preparation:

  • SIAH1 and SIAH2 are both implicated in regulating cellular response to hypoxia

  • Establish consistent hypoxia conditions (1-2% O₂) using validated hypoxia chambers

  • Include time-course experiments to capture dynamic changes in SIAH1/SIAH2 expression

• Stress response protocols:

  • For ischemia/reperfusion models, standardize duration of both ischemia (e.g., 30 min) and reperfusion (e.g., 24h)

  • In Langendorff ex vivo heart preparations, maintain consistent perfusion rates and temperature

  • For oxidative stress models, standardize H₂O₂ concentrations and exposure times

• Sample collection and processing:

  • Harvest samples rapidly to preserve stress-induced protein modifications

  • Include phosphatase inhibitors in lysis buffers to maintain post-translational modifications

  • Consider subcellular fractionation to detect stress-induced translocation

• Controls and normalization:

  • Include appropriate time-matched normoxic controls

  • For stress models, include both positive controls (known stress-responsive proteins) and negative controls

  • Use consistent loading controls that are stable under hypoxic conditions

• Data interpretation considerations:

  • Expect potential changes in both protein abundance and localization

  • SIAH2 has been implicated in regulating cellular response to hypoxia

  • Consider analysis of downstream targets to confirm functional impacts

When studying SIAH1/SIAH2 in cardiac ischemia/reperfusion models, remember that in vivo RNAi of SIAH1/2 resulted in significant cardioprotection, reducing infarct size and improving cardiac function, confirming their important role in stress response pathways .